TD Asset Management’s Lyell Immunopharma LYEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-50,232
Closed -$444K 1269
2025
Q2
$444K Hold
50,232
﹤0.01% 1142
2025
Q1
$540K Hold
50,232
﹤0.01% 1137
2024
Q4
$643K Hold
50,232
﹤0.01% 1162
2024
Q3
$1.52M Hold
50,232
﹤0.01% 1113
2024
Q2
$1.46M Buy
50,232
+2,040
+4% +$97.1K ﹤0.01% 1084
2024
Q1
$2.15M Buy
48,192
+2,380
+5% +$102K ﹤0.01% 996
2023
Q4
$1.78M Hold
45,812
﹤0.01% 1047
2023
Q3
$1.35M Buy
45,812
+24,216
+112% +$1.15M ﹤0.01% 1068
2023
Q2
$1.37M Buy
21,596
+12,612
+140% +$698K ﹤0.01% 1057
2023
Q1
$424K Hold
8,984
﹤0.01% 1298
2022
Q4
$624K Hold
8,984
﹤0.01% 1240
2022
Q3
$1.33M Hold
8,984
﹤0.01% 1113
2022
Q2
$1.17M Hold
8,984
﹤0.01% 1152
2022
Q1
$907K Buy
8,984
+550
+7% +$66.6K ﹤0.01% 1250
2021
Q4
$1.31M Buy
8,434
+2,802
+50% +$625K ﹤0.01% 1231
2021
Q3
$1.67M Buy
5,632
+1,308
+30% +$392K ﹤0.01% 1135
2021
Q2
$1.25M Buy
+4,324
New +$1.42M ﹤0.01% 1210

Other funds holding LYEL